196931 Age-related eye diseases in the United States, 2002 and 2008

Monday, November 9, 2009: 12:33 PM

Asel Ryskulova, MD, PhD, MPH , Office of Analysis, Epidemiology and Health Promotion, National Center for Health Statistics, CDC, Hyattsville, MD
Richard Klein, MPH , Office of Analysis and Epidemiology, National Center for Health Statistics, CDC, Hyattsville, MD
Age-related eye diseases (ED) are leading causes of visual impairment. The average lifetime cost for one person with visual impairment is estimated to be about $601,000 (in 2003 dollars). In 2002 and 2008 the National Health Interview Survey, a nationally representative household survey, included a special vision supplement. This supplement was used to estimate prevalence of the selected ED by demographic characteristics and diagnosed diabetes. Data were analyzed using SUDAAN software to account for a complex survey design.

In 2002 among US adults 18 years and older, the estimated prevalence rates for selected ED were: cataract - 8.6%, glaucoma - 2.0%, macular degeneration - 1.1%, and diabetic retinopathy 0.7%. The prevalence of diabetic retinopathy among persons with diabetes was 9.9%. About 30.1% of persons with cataract, 33.1% of persons with glaucoma, 50.4% of persons with macular degeneration, and 52.1% of persons with diabetic retinopathy reported having impaired vision. The prevalence of ED increased significantly with increasing age, particularly in people over age 65. Age-adjusted prevalence of ED was higher among women, adults with diabetes, adults with low income, and adults with less than a high school education than their respective counterparts.

The 2008 data will be available by fall 2009 and will provide the most recent national data that will allow obtaining the new prevalence estimates and monitoring data trends.

Learning Objectives:
To identify the prevalence of visual impairment and eye diseases among US population To recognize the socioeconomic and demographic characteristics that are associated with increased likelihood for visual impairment and eye diseases

Keywords: Aging, Vision Care

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I made the data analysis and wrote an abstract.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.